Obesity pharmacotherapy (GLP-1 / GIP)
This page brings together scientific sources and reference guidelines on Obesity pharmacotherapy (GLP-1 / GIP), and explains how Cibus AI can support nutrition professionals in daily practice.
How Cibus AI helps with Obesity pharmacotherapy (GLP-1 / GIP)
Cibus does not replace professional judgment: it automates manual work so nutritionists, dietitians and doctors can spend more time with patients with Obesity pharmacotherapy (GLP-1 / GIP).
Evidence-based meal plans
Build diets aligned with reference guidelines for Obesity pharmacotherapy (GLP-1 / GIP), with automatic nutrient calculation.
Anamnesis and digital records
Collect clinical history, parameters and goals of the patient with Obesity pharmacotherapy (GLP-1 / GIP) in one always-updated place.
Automatic transcription and notes
The visit is transcribed and summarized by AI: less paperwork, more time for the patient.
Monitoring and adherence
Reminders, patient app and follow-ups to track progress over time in a structured way.
Scientific sources and reference guidelines
A selection of scientific references and guidelines on Obesity pharmacotherapy (GLP-1 / GIP). The list is not exhaustive and may be updated over time.
- Tirzepatide (Mounjaro) – SURMOUNT-1/2/3/4 trials (NEJM, 2022-2023)
- Semaglutide (Ozempic / Wegovy) – STEP trials (NEJM, 2021)
- ESPEN Guidelines on Clinical Nutrition in Obesity – protein target ≥1.2 g/kg
- AACE/ACE – Obesity Clinical Practice Guidelines (2023)
The listed sources represent the main references on which Cibus AI is trained and updated. The list is constantly evolving and is not exhaustive. Cibus AI is a support tool and does not replace clinical, professional or ethical judgment: every decision remains the full and exclusive responsibility of the professional.
Frequently asked questions
What does the evidence say about Obesity pharmacotherapy (GLP-1 / GIP)?
This page summarizes selected studies and guidelines on Obesity pharmacotherapy (GLP-1 / GIP). Evidence types and certainty vary; no single source proves effectiveness for every population or clinical situation.
Which sources does Cibus AI rely on for Obesity pharmacotherapy (GLP-1 / GIP)?
Cibus AI relies on clinical guidelines, international standards and reference scientific literature for Obesity pharmacotherapy (GLP-1 / GIP), listed on this page and continuously updated.
Does Cibus AI replace clinical judgment?
No. Cibus AI is a support tool: every decision remains the full and exclusive responsibility of the professional.
Spend more time with patients, less on paperwork
Discover how Cibus AI supports your nutrition practice. Try the free demo.
Try Cibus for free